HealO Medical®, LLC

HealO's patented, disruptive wound care platform accelerates the healing of chronic wounds by enhancing blood flow, oxygenation and therapeutic efficacy.

Medical Devices and Equipment

Chronic wounds affect 6.5M patients in the U.S., costing $50B/yr. Average time to healing is a protracted 6-month due to inadequate blood flow and oxygenation. Our award-winning patented therapy platform will cut healing time and costs in ways previously unattainable. FDA clearance is anticipated in January 2020. Based on current CMS reimbursement and 0.16% market share (excluding acute wound care market) net profit of $13.5 million is expected.

Basics

  • Number of Employees
  • Stage
    Full Product Ready
  • Founded
    1970
  • Primary Industry
    Medical Devices and Equipment

Description

Chronic wounds affect 6.5M patients in the U.S., costing $50B/yr. Average time to healing is a protracted 6-month due to inadequate blood flow and oxygenation. Our award-winning patented therapy platform will cut healing time and costs in ways previously unattainable. FDA clearance is anticipated in January 2020. Based on current CMS reimbursement and 0.16% market share (excluding acute wound care market) net profit of $13.5 million is expected.